Please Wait
Applying Filters...
menu
    • menu
    DMF filings rise 4.5% in Q3 2025; China holds lead, India records 20% growth in submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    Hypromellose, Unspecified

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    Product-page Product Main Page
    price-trend Ask Us

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Holder DMF No. Subject Submission Date Status Type GDUFA DMF Review GDUFA Review Date GDUFA Payment Date
    31/10/2025 Pfanstiehl
    U.S.A
    		 PFANSTIEHL INC 19538 SUCROSE NF, EP, JP, ChP HIGH PURITY, LOW ENDOTOXIN, BEET DERIVED (S-124-2-MC) 2006-06-20 Active IV N/A
    31/10/2025 Pfanstiehl
    U.S.A
    		 PFANSTIEHL INC 37676 SUCROSE, NF, EP, JP, CHP HIGH PURITY, LOW ENDOTOXIN - CANE DERIVED 2022-11-11 Active IV N/A